Pathogenicity Genomic Island-Associated CrpP-Like Fluoroquinolone-Modifying Enzymes among Pseudomonas aeruginosa Clinical Isolates in Europe.

Antimicrob Agents Chemother

Medical and Molecular Microbiology, Department of Medicine, Faculty of Science and Medicine, Fribourg, University of Fribourg, Switzerland

Published: June 2020

Many transferable quinolone resistance mechanisms have been identified in Gram-negative bacteria. The plasmid-encoded 65-amino-acid-long ciprofloxacin-modifying enzyme CrpP was recently identified in isolates. We analyzed a collection of 100 clonally unrelated and multidrug-resistant clinical isolates, among which 46 were positive for -like genes, encoding five CrpP variants conferring variable levels of reduced susceptibility to fluoroquinolones. These -like genes were chromosomally located as part of pathogenicity genomic islands.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318011PMC
http://dx.doi.org/10.1128/AAC.00489-20DOI Listing

Publication Analysis

Top Keywords

pathogenicity genomic
8
clinical isolates
8
-like genes
8
genomic island-associated
4
island-associated crpp-like
4
crpp-like fluoroquinolone-modifying
4
fluoroquinolone-modifying enzymes
4
enzymes pseudomonas
4
pseudomonas aeruginosa
4
aeruginosa clinical
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!